Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT00005776
The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure
Inclusion Criteria:
- Greater than 34 wks gestational age
- One or more of the following diagnoses: primary pulmonary hypertension of the newborn,
respiratory distress syndrome, perinatal aspiration syndrome, pneumonia/sepsis,
suspected pulmonary hypoplasia
- Oxygenation Index (OI) greater than 15 and less than 25 on 2 arterial blood gases at
least 15 min apart
- Indwelling arterial line
- Echocardiography before randomization
- Parental consent
Exclusion Criteria:
- Congenital diaphragmatic hernia
- Known congenital heart disease
- Decision not to provide full therapy
drug: Inhaled nitric oxide
drug: Placebo
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305